🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Hereditary Amyloidosis, Transthyretin-Related

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis NCT07695701Phase 41 site📍 St Louis Eidos Therapeutics, a BridgeBio company · Tests: Acoramidis (AG10) oral tablet A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting NCT07235462n/a17 sites📍 Multiple Locations📍 Multiple Locations📍 Multiple Locations Bayer · Tests: Acoramidis (356 mg film-coated tablets) Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis NCT05758493Phase 21 site📍 Portland Oregon Health and Science University · Tests: 124I-Evuzamitide To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy NCT06940336Phase 41 site📍 Jinan Qilu Pharmaceutical Co., Ltd. · Tests: Tafamidis Meglumine Soft Capsules Pan-Amyloid PET/CT in Various Amyloid-Related Disease NCT07130565n/a3 sites📍 Hefei📍 Qingdao📍 Tianjin Tianjin Medical University · Tests: 18F-92/AV45/TPZA/FT8, 11CPIB ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) NCT04561518n/a40 sites📍 La Jolla📍 Los Angeles📍 Jacksonville Alnylam Pharmaceuticals An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy NCT06907186NA1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia · Tests: Psychological Support Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis NCT06465810n/a89 sites📍 La Jolla📍 Los Angeles📍 San Francisco AstraZeneca · Tests: Treatment of transthyretin (ATTR) amyloidosis in observational study setting Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients NCT06845644NA1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Quantitative neuromuscular MRI, Neuromuscular ultrasound Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations NCT07654855n/a6 sites📍 Los Angeles📍 Vancouver📍 Beijing AstraZeneca · Tests: None ( observational study ) A Phase 3 Study of NTLA-2001 in ATTRv-PN NCT06672237Phase 314 sites📍 Buenos Aires📍 Buenos Aires📍 San Juan Bautista Intellia Therapeutics · Tests: nexiguran ziclumeran, Normal Saline as Placebo Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers NCT05489549n/a3 sites📍 New York📍 Cleveland📍 Dallas University of Texas Southwestern Medical Center Phenotypic Manifestations of Hereditary ATTR Amyloidosis NCT07124377n/a2 sites📍 Charata📍 Charata Hospital 9 de Julio de Las Breñas · Tests: A complete physical examination of all body systems, including height and body weight, Neurological examination include… Cardiovascular Multimodality Imaging Study NCT06610019n/a1 site📍 The Bronx Montefiore Medical Center Comprehensive Program for Hereditary Transthyretin Amyloidosis NCT07213297n/a1 site📍 Canuelas Hospital de Alta Complejidad en Red · Tests: clinical assessments and complementary examinations TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy NCT07223203Phase 361 sites📍 Aurora📍 Chicago📍 Baltimore Alnylam Pharmaceuticals · Tests: Nucresiran, Vutrisiran The Eplontersen Pregnancy and Lactation Outcomes Study NCT07205666n/a1 site📍 Frankfurt AstraZeneca MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) NCT06128629Phase 3132 sites📍 Tucson📍 Los Angeles📍 Los Angeles Intellia Therapeutics · Tests: NTLA-2001, Placebo Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant NCT06563895Phase 3104 sites📍 La Jolla📍 Los Angeles📍 San Francisco Eidos Therapeutics, a BridgeBio company · Tests: Acoramidis, Placebo oral tablet Exercise in Hereditary ATTR (ATTRv) Amyloidosis NCT07033715NA1 site📍 Maia University of Maia · Tests: Exercise Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF NCT05577819NA1 site📍 Boston Massachusetts General Hospital · Tests: 99mTc-pyrophosphate Scintigraphy Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study NCT07196839n/a1 site📍 Dallas University of Texas Southwestern Medical Center Phenotyping and Characterization of wtATTR-CM (TRACE 1) NCT06291805n/a1 site📍 Aarhus Steen Hvitfeldt Poulsen Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy NCT07644325NA1 site📍 Montpellier Clinique Saint Jean, France · Tests: Annular ligament biopsy Liver and Coagulation Disorders in Cardiac Transthyretin Amyloidosis NCT07766135n/a1 site📍 Messina University of Messina
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy